| | SLO | ENG | Piškotki in zasebnost

Večja pisava | Manjša pisava

Izpis gradiva Pomoč

Naslov:Chestnut-derived ellagitannins (FT50) protect against western diet-induced metabolic dysfunction and preserve beta cell function in mice
Avtorji:ID Skelin, Maša (Avtor)
ID Polšak, Nika (Avtor)
ID Jakopiček, Jasmina (Avtor)
ID Kovačič, Polona (Avtor)
ID Kopecky, Jan (Avtor)
ID Paradiž, Eva (Avtor)
ID Kerčmar, Jasmina (Avtor)
ID Križančić Bombek, Lidija (Avtor)
ID Dolenšek, Jurij (Avtor)
ID Stožer, Andraž (Avtor)
Datoteke:.pdf RAZ_Skelin_Masa_2026.pdf (2,44 MB)
MD5: 8B79A79817C9A2FFDBD9E5B4613EDEB0
 
URL https://doi.org/10.3389/fendo.2026.1802808
 
URL https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1802808/full
 
Jezik:Angleški jezik
Vrsta gradiva:Znanstveno delo
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Opis:Background: Western diet (WD) consumption accelerates the development of metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM). This study investigated whether chestnut-derived ellagitannins (FT50) modulate early metabolic alterations associated with WD feeding in C57BL/6J male mice. Methods: Male C57BL/6J mice were fed either a western diet (WD) or a WD supplemented with chestnut extract (FT50) for 12 weeks. Body weight, adiposity, glucose tolerance, and indices of insulin action were monitored throughout the study. Glucose and insulin homeostasis were assessed by measuring fasting glucose levels, insulin levels, and the HOMA-IR index. Pancreatic function was evaluated by ex vivo Ca2+ imaging in pancreas tissue slices to assess beta cell activation dynamics and islet network coordination. Results: WD feeding induced significant body weight gain, adiposity, hyperglycemia, glucose intolerance, changes consistent with impaired insulin action, and partially compensatory hyperinsulinemia. Supplementation with FT50 prevented weight gain and fat accumulation, reduced organ hypertrophy, and was associated with improved glucose and insulin-related parameters without affecting the caloric intake. FT50-fed mice showed improved glucose tolerance from week 4 onward, accompanied by a lower HOMA-IR values and reduced hyperinsulinemia, consistent with improved indirect markers of insulin action relative to WD-fed mice. Ex vivo Ca2+ imaging in pancreas tissue slices revealed that in FT50-fed mice, beta cells have higher activation thresholds, longer activation delays, and lower Ca2+ activity during the plateau phase, while their network coordination is preserved. Conclusions: In sum, these effects indicate reduced beta cell excitability and are consistent with an attenuation of early metabolic alterations under WD conditions. Overall, these findings suggest that FT50 supplementation modulates early WD-induced metabolic changes in male mice. However, the study is limited to early-stage alterations, does not address later stages of metabolic disease, and does not establish direct effects on insulin sensitivity. Within these constraints, chestnut extract represents a potentially promising bioactive dietary intervention for modulating early metabolic responses to WD.
Ključne besede:beta cells, calcium imaging, ellagitannins, glucose intolerance, insulin resistance, metabolic syndrome, mouse model, western diet
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Poslano v recenzijo:02.04.2026
Datum sprejetja članka:08.04.2026
Datum objave:30.04.2026
Založnik:Frontiers
Leto izida:2026
Št. strani:str. 1-18
Številčenje:Letn. 17, Apr. 2026
PID:20.500.12556/DKUM-98154 Novo okno
UDK:612.349.7
COBISS.SI-ID:278686211 Novo okno
DOI:10.3389/fendo.2026.1802808 Novo okno
ISSN pri članku:1664-2392
Datum objave v DKUM:21.05.2026
Število ogledov:174
Število prenosov:3
Metapodatki:XML DC-XML DC-RDF
Področja:Ostalo
:
Kopiraj citat
  
Skupna ocena:(0 glasov)
Vaša ocena:Ocenjevanje je dovoljeno samo prijavljenim uporabnikom.
Objavi na:Bookmark and Share



Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Frontiers in endocrinology
Založnik:Frontiers Research Foundation
ISSN:1664-2392
COBISS.SI-ID:3340154 Novo okno

Gradivo je financirano iz projekta

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P3-0396-2019
Naslov:Celične in tkivne mreže

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:I0-0029-2022
Naslov:Infrastrukturna dejavnost Univerze v Mariboru

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J3-60062-2025
Naslov:Vpliv aminokislin na delovanje omrežja celic v Langerhansovih otočkih

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:N3-0484-2026
Naslov:Mehanistični vpogled v eksokrino–endokrino sodelovanje: endokrina disfunkcija pri pankreatitisu in spremembe v eksokrini funkciji pri sladkorni bolezni

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J1-70030
Naslov:Razvoj Langerhansovih otočkov in vitro za analizo endokrine funkcije

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Komentarji

Dodaj komentar

Za komentiranje se morate prijaviti.

Komentarji (0)
0 - 0 / 0
 
Ni komentarjev!

Nazaj
Logotipi partnerjev Univerza v Mariboru Univerza v Ljubljani Univerza na Primorskem Univerza v Novi Gorici